LOS ANGELES, Calif., May 18, 2010 – Emmaus Medical, Inc., the privately‐held pharmaceutical company developing and bringing to market a promising new treatment for sickle‐cell disease, announced today that Henry (Hank) McKinnell, Jr., PhD, has joined the board of directors.